ERBB2 and neoplasm: We previously documented a correspondingly smaller [lactate]-to-[glucose] ratio in ErbB2-induced breast carcinomas relative to carcinogen-induced breast carcinomas [7, 8], which is indicative of lower fermentative glycolysis and can explain the difference in tumor acidification.